Enter your login e-mail to the account
Search
- Inhibition ALK and ROS1 in the treatment of metastatic non-small lung cancer – new treatment options and recommendations
MUDr. Lucia Denková
(1/2021, Main topic ) - Treatment of ALK-rearranged non-small cell lung cancer
MUDr. Zuzana Pribulová
(6/2015, Main topic ) - Lorlatinib in 1st line ALK-positive non-small cell lung cancer
MUDr. Lucia Denková
(4/2024, Drugs & drug classes )